CN112807293B - 甲磺酸去铁胺在制备治疗中耳炎药物中的应用 - Google Patents
甲磺酸去铁胺在制备治疗中耳炎药物中的应用 Download PDFInfo
- Publication number
- CN112807293B CN112807293B CN202110226367.5A CN202110226367A CN112807293B CN 112807293 B CN112807293 B CN 112807293B CN 202110226367 A CN202110226367 A CN 202110226367A CN 112807293 B CN112807293 B CN 112807293B
- Authority
- CN
- China
- Prior art keywords
- otitis media
- deferoxamine mesylate
- medicine
- preparation
- application
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110226367.5A CN112807293B (zh) | 2021-03-01 | 2021-03-01 | 甲磺酸去铁胺在制备治疗中耳炎药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110226367.5A CN112807293B (zh) | 2021-03-01 | 2021-03-01 | 甲磺酸去铁胺在制备治疗中耳炎药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112807293A CN112807293A (zh) | 2021-05-18 |
CN112807293B true CN112807293B (zh) | 2023-06-02 |
Family
ID=75862684
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110226367.5A Active CN112807293B (zh) | 2021-03-01 | 2021-03-01 | 甲磺酸去铁胺在制备治疗中耳炎药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112807293B (zh) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102905697A (zh) * | 2010-03-22 | 2013-01-30 | 医疗研究局 | 靶向vegf和/或hif途径、用于治疗中耳炎的化合物如索拉非尼或瓦他拉尼 |
CN107184570A (zh) * | 2017-06-02 | 2017-09-22 | 中国科学院遗传与发育生物学研究所 | 去铁胺在制备用于治疗非酒精性脂肪肝的药物中的应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102526005B (zh) * | 2011-12-23 | 2013-07-10 | 苏州大学 | 甲磺酸去铁胺在制备治疗绝经后骨质疏松疾病药物中的用途 |
-
2021
- 2021-03-01 CN CN202110226367.5A patent/CN112807293B/zh active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102905697A (zh) * | 2010-03-22 | 2013-01-30 | 医疗研究局 | 靶向vegf和/或hif途径、用于治疗中耳炎的化合物如索拉非尼或瓦他拉尼 |
CN107184570A (zh) * | 2017-06-02 | 2017-09-22 | 中国科学院遗传与发育生物学研究所 | 去铁胺在制备用于治疗非酒精性脂肪肝的药物中的应用 |
Non-Patent Citations (1)
Title |
---|
药物性耳聋的预防和治疗现状;宋永玲等;《山东大学耳鼻喉眼学报》;20090616;第23卷(第03期);第34-37页 * |
Also Published As
Publication number | Publication date |
---|---|
CN112807293A (zh) | 2021-05-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Meli et al. | Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis | |
Klein et al. | Meningitis‐associated hearing loss: protection by adjunctive antioxidant therapy | |
BENITEZ et al. | Pathologic changes in human ear after kanamycin | |
US4607038A (en) | Ophthalmic pranoprofen compositions | |
Grote et al. | Middle ear effusion and sinusitis | |
Zhao et al. | ROS-responsive nanoparticle as a berberine carrier for OHC-targeted therapy of noise-induced hearing loss | |
JPH01258620A (ja) | 耳疾患用局所製剤 | |
Tarlow et al. | Endotoxin induced damage to the cochlea in guinea pigs. | |
CN112807293B (zh) | 甲磺酸去铁胺在制备治疗中耳炎药物中的应用 | |
Roland et al. | Disorders of the external auditory canal. | |
Okuda et al. | Inhibition of caspases alleviates gentamicin-induced cochlear damage in guinea pigs | |
Tsuprun et al. | Role of pneumococcal proteins in sensorineural hearing loss due to otitis media | |
KR102099363B1 (ko) | 아보카도 오일 분획을 유효성분으로 포함하는 난청의 예방 또는 치료용 약학적 조성물 | |
AT509045B1 (de) | Verbindungen zur behandlung von asthma bronchiale | |
Ohki et al. | Fungal mastoiditis in an immunocompetent adult | |
Cook et al. | Cytotoxic changes in hair cells secondary to pneumococcal middle-ear infection | |
Worsøe et al. | Intratympanic steroid prevents long-term spiral ganglion neuron loss in experimental meningitis | |
Oishi et al. | Burow's solution-induced acute sensorineural hearing loss: Report of two cases | |
Midholm et al. | Primary tuberculos otitis media | |
KR102151152B1 (ko) | 난청의 예방 또는 치료용 조성물 | |
Hirashima | Treatment of sudden deafness with sodium salts of triiodobenzoic acid derivatives | |
KR102151155B1 (ko) | 난청의 예방 또는 치료용 조성물 | |
WO2018034910A1 (en) | Novel compositions and methods for cerumen removal | |
McKelvie et al. | The effect of gentamycin ear drops on the cochlea | |
Whitehead | A Case of Primary Epithelioma (?) of the Tympanum Following Chronic Suppurative Otitis Media |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20230331 Address after: No.308 Ningxia road, Qingdao, Shandong 266000 Applicant after: QINGDAO University Applicant after: BINZHOU MEDICAL University Address before: 264003 Binzhou Medical College, 346 Guanhai Road, Laishan District, Yantai City, Shandong Province Applicant before: BINZHOU MEDICAL University |
|
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Ma Peng Inventor after: Li Bo Inventor after: Zheng Qingyin Inventor after: Yan Bin Inventor after: Zheng Tihua Inventor after: Xie Daoli Inventor after: Zhang Xiaolin Inventor before: Li Bo Inventor before: Zheng Qingyin Inventor before: Yan Bin Inventor before: Zheng Tihua Inventor before: Xie Daoli Inventor before: Zhang Xiaolin |
|
GR01 | Patent grant | ||
GR01 | Patent grant |